Skip to content

Dr. Tine Grégoir

Active
Private limited companyfounded 2023active for 3 yearsGroot Park 1G/7, 3360 Bierbeek, BelgiumKBO/BCE: BE 0801.684.907
Summary

Dr. Tine Grégoir has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €4,980 and a net result of -€1,800. Its solvency ranks better than 71% of 20,700 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 11-05-2023 Normal situation
Activity
Specialist medical practice NACE 86220and 3 others
Establishment unit
2.345.763.668 3360 Bierbeek, since 11-05-2023
Financial year end
31 December
Peppol
Reachable since 21-10-2026

Board and ownership

Board

Financial position

93 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
-€1,430
▲ 88.1%
Loss
€1,800
▼ 86.4%
Equity
€4,980
▼ 26.6%
Total assets
€6,163
▼ 50.6%
Turnover not published (micro format)
Score breakdownlowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 4.16, cash €3,886, halvedSize: total assets €6,163Figures for financial year 2025 (filed on 31-07-2026)Show the evidence

Checked score

Score 2025
93 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 46% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 100+21
equity 80.8% of total assets
Liquidity 94+16
short-term debt 19.2% · cash 63.1%
Profitability 0=
return on assets -29.2%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 12-2024: 0.4% 01-2025: 0.4%● unchanged vs 12-2024 02-2025: 0.4%● unchanged vs 01-2025 03-2025: 0.4%● unchanged vs 02-2025 04-2025: 0.4%● unchanged vs 03-2025 05-2025: 0.4%● unchanged vs 04-2025 06-2025: 0.4%● unchanged vs 05-2025highest value 07-2025: 0.4%● unchanged vs 06-2025 08-2025: < 0.1%▼ -0.4 percentage points vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: 0.1%▲ +0.1 percentage points vs 06-2026 08-2026: < 0.1%▼ -0.1 percentage points vs 07-2026lowest value 09-2026: < 0.1%● unchanged vs 08-2026lowest value 10-2026: < 0.1%● unchanged vs 09-2026lowest value 11-2026: < 0.1%● unchanged vs 10-2026lowest value
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 81% on liquidity, 1% on profitability and 19% on growth.

The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 4.16, cash €3,886, halved
NBB · annual accounts
lowers risk · Size: total assets €6,163
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 31-07-2026)
NBB · annual accounts
raises risk · Persistent losses
Two consecutive loss-making years (2024 and 2025); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2025
Net result per financial year
2425
2024 to 2025 · latest year -€1,800
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-07-2026, 0 days ahead of the deadline.
NBB · 2 filings
Deviation from the deadline
2025
on the day
2024
23 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 2 accounts on average 12 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Where today falls in the filing period
02-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2023.
KBO publications

Key points

  • Caution: Lower net result than 92% of companies in human healthsector median €60,156 · 20,687 companies -€1,800 View

Recent changes

  1. · Gazette deed IncorporationAppointment: GRÉGOIR Tine Trees (director and managing director)
All 3 events

Comparable companies

These companies have the same main activity as Dr. Tine Grégoir: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €5,000 and €7,480, founded between 2020 and 2024.

CompanyTotal assetsGross margin
Dr. Tine Grégoir Bierbeek€6,163-€1,430
Pizo Herent€6,383-€23,322
Dokter Lina Del Favero Glabbeek€7,475-€2,531
Pneumologen Maaseik Maaseik€5,534€751
Dr. J.Verbeke, arts Gent€5,448-€11,057
Dr. Matic Milica Schaarbeek€5,000-€1,601
WeFace Evergem€7,381-€5,526
Full comparison

Key facts about Dr. Tine Grégoir

What is the company number of Dr. Tine Grégoir?
The company number of Dr. Tine Grégoir is 0801.684.907. The VAT number is the same number with BE in front: BE 0801.684.907.
Where is Dr. Tine Grégoir based?
The registered office is at Groot Park 1G/7, 3360 Bierbeek.Company details
What does Dr. Tine Grégoir do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Dr. Tine Grégoir?
The legal form of Dr. Tine Grégoir is Private limited company (BV).
When was Dr. Tine Grégoir founded?
Dr. Tine Grégoir was founded on 11-05-2023.
Is Dr. Tine Grégoir still active?
Yes, Dr. Tine Grégoir is an active enterprise in the KBO register.
What is the turnover of Dr. Tine Grégoir?
The annual accounts for financial year 2025 state no turnover. The micro format does not require it.Financials
Is Dr. Tine Grégoir profitable?
In financial year 2025, Dr. Tine Grégoir made a loss of €1,800.
Where can I find the annual accounts of Dr. Tine Grégoir?
Dr. Tine Grégoir filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Tine Grégoir due?
Dr. Tine Grégoir must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.